← The Wire
MAIANYSE
MAIA Biotechnology, Inc.
Pharmaceutical Preparations · DE · CIK 1878313
MAIA Biotechnology develops targeted immunotherapies for cancer, including its lead asset ateganosine
red 8-K · 90d
$79M
Market cap
$1.48
Last close
+5.0%
1D
+7.3%
5D
772K
Volume
Price · last 39 sessions+6.5%
May 4L $1.23 · H $1.50Jun 29
165
Total filings
May 22, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteMay 22, 2026DEFA14ADEFA14AMay 19, 20268-KAgreement TerminatedMay 14, 2026424B5424B5May 14, 202610-Q10-QMay 11, 2026DEFA14ADEFA14AApr 27, 20268-KCompany UpdateApr 16, 20268-KCompany UpdateApr 8, 2026DEFA14ADEFA14AApr 7, 2026DEF 14ADEF 14AApr 7, 20268-KExecutive ChangeApr 2, 20268-KCompany UpdateMar 31, 20268-KReg FD Disclosure · Company UpdateMar 27, 202610-K10-KMar 23, 20268-KMaterial Agreement · Company UpdateMar 4, 2026424B5424B5Mar 4, 2026424B5424B5Mar 2, 20268-KCompany UpdateFeb 24, 20268-KCompany UpdateJan 20, 20268-KReg FD Disclosure · Company UpdateJan 13, 20268-KMaterial Agreement · Equity IssuanceDec 17, 20258-KCompany UpdateDec 11, 20258-KCompany UpdateDec 10, 2025SC 13D/ASC 13D/ADec 4, 20258-KCompany UpdateNov 21, 20258-KCompany UpdateNov 20, 202510-Q10-QNov 7, 20258-KCompany UpdateNov 7, 20258-KCompany UpdateOct 27, 20258-KCompany UpdateOct 24, 20258-KReg FD Disclosure · Company UpdateOct 23, 20258-KMaterial Agreement · Equity IssuanceOct 14, 20258-KCompany UpdateOct 7, 20258-KMaterial Agreement · Equity IssuanceSep 30, 20258-KCompany UpdateSep 24, 20258-KMaterial Agreement · Equity IssuanceSep 18, 20258-KCompany UpdateSep 12, 20258-KCompany UpdateSep 11, 20258-KReg FD Disclosure · Company UpdateSep 8, 20258-KCompany UpdateAug 13, 202510-Q10-QAug 11, 20258-KCompany UpdateJul 28, 20258-KCompany UpdateJul 17, 20258-KCompany UpdateJul 9, 20258-KMaterial Agreement · Equity IssuanceJun 26, 20258-KCompany UpdateJun 24, 20258-KCompany UpdateJun 18, 20258-KMaterial Agreement · Equity IssuanceJun 17, 20258-KCompany UpdateJun 5, 20258-KReg FD Disclosure · Company UpdateJun 2, 20258-KMaterial Agreement · Equity IssuanceMay 28, 20258-KBylaw AmendmentMay 23, 20258-KShareholder Vote · Company UpdateMay 22, 202510-Q10-QMay 9, 20258-KMaterial Agreement · Equity IssuanceMay 6, 20258-KCompany UpdateApr 22, 2025DEFA14ADEFA14AApr 8, 2025DEF 14ADEF 14AApr 8, 20258-KCompany UpdateApr 1, 20258-KReg FD DisclosureMar 28, 20258-KCompany UpdateMar 26, 2025424B5424B5Mar 26, 20258-KCompany UpdateMar 21, 202510-K10-KMar 21, 20258-KCompany UpdateMar 19, 20258-KCompany UpdateFeb 27, 20258-KMaterial Agreement · Equity IssuanceFeb 25, 20258-KMaterial Agreement · Equity IssuanceFeb 19, 20258-KExecutive ChangeFeb 6, 20258-KReg FD Disclosure · Company UpdateFeb 5, 20258-KCompany UpdateDec 23, 2024424B5424B5Dec 23, 20248-KCompany UpdateDec 20, 20248-KMaterial Agreement · Equity IssuanceDec 10, 202410-Q10-QNov 12, 20248-KReg FD DisclosureNov 8, 20248-KCompany UpdateNov 5, 20248-KMaterial Agreement · Equity IssuanceOct 29, 2024SC 13DSC 13DOct 25, 2024SC 13DSC 13DOct 25, 2024
Insider Activity
◆ Cluster Buy · 5 insidersIn the 90 days to Dec 22, 2025: 5 insiders bought $539K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 22, 2025 | Louie Ngar YeeDirector | Buy | 81,699 | $1.22 | $100K |
| Dec 22, 2025 | Smith StanDirector | Buy | 57,189 | $1.22 | $70K |
| Dec 22, 2025 | Chaouki Steven MDirector | Buy | 40,849 | $1.22 | $50K |
| Dec 5, 2025 | Smith StanDirector | Buy | 4,580 | $1.20 | $5K |
| Dec 5, 2025 | Smith StanDirector | Buy | 4,580 | $1.19 | $5K |
| Nov 28, 2025 | Vitoc VladChief Executive Officer | Buy | 50,000 | $1.14 | $57K |
| Nov 28, 2025 | Vitoc VladChief Executive Officer | Buy | 50,000 | $1.14 | $57K |
| Nov 28, 2025 | Luput CristianDirector | Buy | 18,145 | $1.11 | $20K |
| Nov 26, 2025 | Vitoc VladChief Executive Officer | Buy | 22,000 | $1.05 | $23K |
| Nov 26, 2025 | Vitoc VladChief Executive Officer | Buy | 22,000 | $1.05 | $23K |
| Nov 26, 2025 | Luput CristianDirector | Buy | 20,000 | $1.08 | $22K |
| Nov 26, 2025 | Smith StanDirector | Buy | 15,000 | $1.04 | $16K |
| Nov 25, 2025 | Smith StanDirector | Buy | 15,000 | $0.98 | $15K |
| Nov 25, 2025 | Vitoc VladChief Executive Officer | Buy | 10,500 | $0.97 | $10K |
| Nov 25, 2025 | Vitoc VladChief Executive Officer | Buy | 10,500 | $0.97 | $10K |
| Nov 25, 2025 | Luput CristianDirector | Buy | 10,000 | $0.98 | $10K |
| Nov 24, 2025 | Vitoc VladChief Executive Officer | Buy | 10,000 | $0.99 | $10K |
| Nov 24, 2025 | Smith StanDirector | Buy | 10,000 | $0.99 | $10K |
| Nov 21, 2025 | Vitoc VladChief Executive Officer | Buy | 1,800 | $0.92 | $2K |
| Oct 1, 2025 | Smith StanDirector | Buy | 19,230 | $1.30 | $25K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance